Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues. •MS services keep making efforts to ensure the safety and standard of care for pwMS during the still-evolving COVID-19 crisis.•We aim to provide updated recommendations on MS management during the COVID-19 crisis and the post-pandemic period.•These recommendations may help HCPs reduce potential risks to pwMS, and to ensure that they receive the best possible care.